Zhejiang CONBA Pharmaceutical Co Ltd (600572) — Capital Reinvestment Ratio
Zhejiang CONBA Pharmaceutical Co Ltd (600572) has a Capital Reinvestment Ratio of 0.20x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥133.43 Million) in capital expenditures (CN¥26.90 Million). See 600572 equity to assets ratio to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Zhejiang CONBA Pharmaceutical Co Ltd Capital Reinvestment Ratio (2003–2025)
This chart tracks Zhejiang CONBA Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 23 annual periods. Check Zhejiang CONBA Pharmaceutical Co Ltd cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Zhejiang CONBA Pharmaceutical Co Ltd (2003–2025)
Year-by-year Capital Reinvestment Ratio for Zhejiang CONBA Pharmaceutical Co Ltd from 2003 to 2025. For live market cap and broader valuation context, see Zhejiang CONBA Pharmaceutical Co Ltd stock valuation.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.16x | CN¥942.61 Million | CN¥147.26 Million | ▼ -45.6% |
| 2024 | 0.29x | CN¥1.01 Billion | CN¥290.63 Million | ▲ +23.3% |
| 2023 | 0.23x | CN¥898.64 Million | CN¥209.14 Million | ▼ -7.8% |
| 2022 | 0.25x | CN¥1.16 Billion | CN¥291.75 Million | ▼ -60.5% |
| 2021 | 0.64x | CN¥889.94 Million | CN¥568.37 Million | ▲ +73.4% |
| 2020 | 0.37x | CN¥1.25 Billion | CN¥460.40 Million | ▲ +26.9% |
| 2019 | 0.29x | CN¥925.50 Million | CN¥268.79 Million | ▼ -58.2% |
| 2018 | 0.70x | CN¥545.78 Million | CN¥379.63 Million | ▲ +69.8% |
| 2017 | 0.41x | CN¥712.27 Million | CN¥291.80 Million | ▲ +71.4% |
| 2016 | 0.24x | CN¥969.71 Million | CN¥231.83 Million | ▼ -30.8% |
| 2015 | 0.35x | CN¥831.26 Million | CN¥286.97 Million | ▼ -50.3% |
| 2014 | 0.70x | CN¥617.43 Million | CN¥429.23 Million | ▼ -65.7% |
| 2013 | 2.02x | CN¥235.36 Million | CN¥476.32 Million | ▲ +107.4% |
| 2012 | 0.98x | CN¥245.76 Million | CN¥239.76 Million | ▲ +38.1% |
| 2011 | 0.71x | CN¥188.36 Million | CN¥133.09 Million | ▼ -21.3% |
| 2010 | 0.90x | CN¥125.93 Million | CN¥113.07 Million | ▲ +158.3% |
| 2009 | 0.35x | CN¥153.39 Million | CN¥53.32 Million | ▼ -57.8% |
| 2008 | 0.82x | CN¥98.56 Million | CN¥81.12 Million | ▼ -19.5% |
| 2007 | 1.02x | CN¥79.98 Million | CN¥81.83 Million | ▲ +10.9% |
| 2006 | 0.92x | CN¥71.20 Million | CN¥65.67 Million | ▼ -6.9% |
| 2005 | 0.99x | CN¥117.65 Million | CN¥116.57 Million | ▲ +1.7% |
| 2004 | 0.97x | CN¥65.47 Million | CN¥63.81 Million | ▲ +61.0% |
| 2003 | 0.61x | CN¥66.64 Million | CN¥40.34 Million | — |